Literature DB >> 11407474

Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability.

J Palacios1, L Catasús, G Moreno-Bueno, X Matias-Guiu, J Prat, C Gamallo.   

Abstract

The activation of the adenomatous polyposis coli (APC)/beta-catenin/T-cell factor (Tcf) pathway due to beta-catenin gene mutation has been recently implicated in the development of some endometrial carcinomas. beta- and gamma-catenin are structurally and functionally related molecules that participate in cell adhesion and signal transduction. Nuclear accumulation of beta- and gamma-catenin have been related to the activation of the APC/beta-catenin/Tcf pathway. In this study, we investigate the immunohistochemical expression pattern (nuclear vs membranous) of beta- and gamma-catenin in 40 endometrial carcinomas and their correlation with clinicopathological features and microsatellite instability (MI) status. MI was detected at three or more loci in 12 tumors: 11 were endometrioid and one was non-endometrioid. Nuclear catenin expression was found in 13 carcinomas: ten carcinomas had nuclear beta-catenin expression and three carcinomas had nuclear gamma-catenin expression. The nuclear catenin expression pattern significantly correlated with the histological type, International Federation of Gynecology and Obstetrics (FIGO) grade, and the presence of a second neoplasm. Nuclear catenin expression was always observed in low-grade endometrioid carcinomas; it was also more frequently associated with a second carcinoma. No correlation was observed between the catenin expression pattern and the level of myometrial infiltration, stage, associated endometrial hyperplasia, the existence of a source of estrogenic stimulation, and MI. However, four of 13 endometrioid carcinomas in this series had both catenin nuclear expression and MI. These data suggest that at least two different neoplastic pathways can lead to endometrial carcinomas with an endometrioid phenotype. In one, MI would be a key event, while in the other, the APC/beta-catenin/Tcf signaling pathways could be activated. Probably, in some cases, both pathways could simultaneously occur.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11407474     DOI: 10.1007/s004280000371

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  7 in total

1.  APC and beta-catenin protein expression patterns in HNPCC-related endometrial and colorectal cancers.

Authors:  Reetta Kariola; Wael M Abdel-Rahman; Miina Ollikainen; Ralf Butzow; Päivi Peltomäki; Minna Nyström
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

2.  Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.

Authors:  K A Voutilainen; M A Anttila; S M Sillanpää; K M Ropponen; S V Saarikoski; M T Juhola; V-M Kosma
Journal:  J Clin Pathol       Date:  2006-02-03       Impact factor: 3.411

Review 3.  Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.

Authors:  Sigurd F Lax
Journal:  Virchows Arch       Date:  2004-01-28       Impact factor: 4.064

Review 4.  Molecular determinants of invasion in endometrial cancer.

Authors:  M Abal; M Llauradó; A Doll; M Monge; E Colas; M González; M Rigau; H Alazzouzi; S Demajo; J Castellví; A García; S Ramón y Cajal; J Xercavins; M H Vázquez-Levin; F Alameda; A Gil-Moreno; J Reventos
Journal:  Clin Transl Oncol       Date:  2007-05       Impact factor: 3.405

5.  Crosstalk of estrogen receptors and Wnt/β-catenin signaling in endometrial cancer.

Authors:  Mariz Kasoha; Chrisoula Dernektsi; Anita Seibold; Rainer M Bohle; Zoltan Takacs; Iordache Ioan-Iulian; Erich-Franz Solomayer; Ingolf Juhasz-Böss
Journal:  J Cancer Res Clin Oncol       Date:  2019-12-21       Impact factor: 4.553

Review 6.  Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.

Authors:  Tanri Shiozawa; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.850

7.  Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.

Authors:  Ignacio Ruz-Caracuel; Álvaro López-Janeiro; Victoria Heredia-Soto; Jorge L Ramón-Patino; Laura Yébenes; Alberto Berjón; Alicia Hernández; Alejandro Gallego; Patricia Ruiz; Andrés Redondo; Alberto Peláez-García; Marta Mendiola; David Hardisson
Journal:  Virchows Arch       Date:  2021-08-21       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.